Fewer report using a screening tool at every well visit
THURSDAY, May 22, 2025 (HealthDay News) — Just over half of youth-serving clinicians report that they routinely screen adolescents for substance use disorders (SUDs) at every well visit, according to a study published online May 20 in JAMA Network Open.
Kathleen Ragan-Burnett, M.S.P.H., from the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention in Atlanta, and colleagues assessed youth-serving clinicians’ screening, brief intervention, and referral to treatment practices for SUDs among adolescents. The analysis included survey responses from 1,047 youth-serving clinicians.
The researchers found that most clinicians (60.6 percent) reported that skills in SUD diagnosis were relevant to their practice, and 76.4 percent reported seeing at least one adolescent with an SUD monthly. Just over half of clinicians (56.9 percent) reported screening for SUDs at every well visit, with a high proportion of pediatricians reporting screening at every well visit (69.2 percent). Just over one-third of clinicians (39.3 percent) reported screening at every well visit using a screening tool and just under one-third of clinicians (30.7 percent) offered all components of screening, brief intervention, and referral to treatment practice.
“Efforts to improve screening rates through education and systems-based practice changes may facilitate offering anticipatory guidance and SUD treatment in all youth-serving clinical settings,” the authors write.
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis